propranolol has been researched along with bumetanide in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.50) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 11 (45.83) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hedge, RS; Palfrey, HC; Pewitt, EB | 1 |
| Ballard, ST; Boucher, RC; Gatzy, JT; Krochmal, EM; Yankaskas, JR | 1 |
| Ishida, H; Suzuki, Y | 1 |
| De Soignie, R; Sellin, JH | 1 |
| Demedts, MG; Pype, JL; Verleden, GM | 1 |
| Wojciechowska, I | 1 |
| Gosmanov, AR; Schneider, EG; Thomason, DB; Wong, JA | 1 |
| Folkesson, HG; Norlin, A; Ye, X | 1 |
2 review(s) available for propranolol and bumetanide
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
22 other study(ies) available for propranolol and bumetanide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[3H]bumetanide binding to avian erythrocyte membranes. Correlation with activation and deactivation of Na/K/2Cl cotransport.
Topics: Animals; Binding Sites; Bumetanide; Carrier Proteins; Chlorides; Diuretics; Ducks; Erythrocyte Membrane; Erythrocytes; Fluorides; Hypertonic Solutions; Kinetics; Norepinephrine; Potassium; Propranolol; Rubidium; Sodium; Sodium-Potassium-Chloride Symporters | 1990 |
Volume and ion transport by fetal rat alveolar and tracheal epithelia in submersion culture.
Topics: Amiloride; Animals; Biological Transport; Bumetanide; Dinitrophenols; Epithelial Cells; Epithelium; Fetus; Iodoacetamide; Ions; Microscopy, Electron; Organ Culture Techniques; Ouabain; Propranolol; Pulmonary Alveoli; Rats; Rats, Inbred Strains; Terbutaline; Trachea | 1989 |
Potassium secretion in the guinea pig distal colon.
Topics: Animals; Barium; Bumetanide; Colon; Electric Conductivity; Epinephrine; Female; Guinea Pigs; Isoproterenol; Phentolamine; Potassium; Propranolol; Receptors, Adrenergic, beta; Serous Membrane; Tetraethylammonium Compounds | 1987 |
Regulation of Na-Cl absorption in rabbit proximal colon in vitro.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; Animals; Bumetanide; Colon; Epinephrine; Furosemide; In Vitro Techniques; Intestinal Absorption; Kinetics; Male; Prazosin; Propranolol; Rabbits; Sodium Chloride; Yohimbine | 1987 |
Furosemide and bumetanide, but not nedocromil sodium, modulate nonadrenergic relaxation in guinea pig trachea in vitro.
Topics: Animals; Arginine; Atropine; Bumetanide; Chymotrypsin; Drug Therapy, Combination; Electric Stimulation; Female; Furosemide; Guinea Pigs; In Vitro Techniques; Indomethacin; Male; Muscle Relaxation; Nedocromil; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Premedication; Propranolol; Trachea; Vasoactive Intestinal Peptide | 1994 |
[Influence of stimulation and inhibition of adrenergic receptors on ion transport in isolated rabbit trachea in electrophysiologic investigations].
Topics: Adrenergic Agonists; Adrenergic Antagonists; Animals; Bumetanide; Electrophysiology; Epinephrine; Female; In Vitro Techniques; Indomethacin; Ion Transport; Male; Phentolamine; Physical Stimulation; Propranolol; Rabbits; Receptors, Adrenergic; Stimulation, Chemical; Trachea | 1999 |
Insulin-independent, MAPK-dependent stimulation of NKCC activity in skeletal muscle.
Topics: Adrenergic Agonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Biological Transport, Active; Bumetanide; Butadienes; Carrier Proteins; Diuretics; Electric Stimulation; Enzyme Inhibitors; Epinephrine; Female; Flavonoids; In Vitro Techniques; Insulin; Isoproterenol; Mitogen-Activated Protein Kinases; Muscle Contraction; Muscle, Skeletal; Nitriles; Phenylephrine; Prazosin; Propranolol; Rats; Rats, Sprague-Dawley; Rubidium Radioisotopes; Sodium-Potassium-Chloride Symporters | 2001 |
Stimulation of distal airspace fluid clearance in guinea pigs involves bumetanide-sensitive ion transport.
Topics: Absorption; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Body Fluids; Bumetanide; Diuretics; Epinephrine; Epithelium; Fetus; Gestational Age; Guinea Pigs; Ion Transport; Lung; Propranolol; Receptors, Adrenergic, beta | 2004 |